| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3871 |
| Trial ID | NCT06393335 |
| Disease | Acute Lymphoblastic Leukemia | Non-Hodgkin's Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical Research |
| Year | 2024 |
| Country | China |
| Company sponsor | The Children's Hospital of Zhejiang University School of Medicine |
| Other ID(s) | Meta10-19-005 |
| Cohort 1 | |||||||||
|
|||||||||